Evidence map›Paper›PMID 26133781›Full record

ArticlePloS one2015

Effects of Endocrine Disruptor Compounds, Alone or in Combination, on Human Macrophage-Like THP-1 Cell Response.

N Couleau, J Falla, A Beillerot, E Battaglia, M D'Innocenzo, S Plançon, P Laval-Gilly, A Bennasroune

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Can Antioxidants Reduce the Toxicity of Bisphenol?Antioxidants (Basel, Switzerland) · 2022
    Review
  14. Can Exposure to Environmental Pollutants Be Associated with Less Effective Chemotherapy in Cancer Patients?International journal of environmental research and public health · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Critical Review on the Presence of Phthalates in Food and Evidence of Their Biological Impact.International journal of environmental research and public health · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

N CouleauUniversité de Lorraine, CNRS UMR 7360, Laboratoire Interdisciplinaire des Environnements Continentaux (LIEC), IUT Thionville-Yutz, Espace Cormontaigne, Yutz, France.
J FallaUniversité de Lorraine, CNRS UMR 7360, Laboratoire Interdisciplinaire des Environnements Continentaux (LIEC), IUT Thionville-Yutz, Espace Cormontaigne, Yutz, France.
A BeillerotIUT Thionville-Yutz, Impasse Alfred Kastler Espace Cormontaigne, Yutz, France.
E BattagliaUniversité de Lorraine, CNRS UMR 7360, Laboratoire Interdisciplinaire des Environnements Continentaux (LIEC), Campus Bridoux-8, Metz, France.
M D'InnocenzoIUT Thionville-Yutz, Impasse Alfred Kastler Espace Cormontaigne, Yutz, France.
S PlançonCalcium Signaling and Inflammation Group, Life Sciences Research Unit, University of Luxembourg, Luxembourg, Luxembourg.
P Laval-GillyUniversité de Lorraine, CNRS UMR 7360, Laboratoire Interdisciplinaire des Environnements Continentaux (LIEC), IUT Thionville-Yutz, Espace Cormontaigne, Yutz, France.
A BennasrouneUniversité de Lorraine, CNRS UMR 7360, Laboratoire Interdisciplinaire des Environnements Continentaux (LIEC), IUT Thionville-Yutz, Espace Cormontaigne, Yutz, France.
Laboratoire Interdisciplinaire des Environnements Continentaux · FRCentre National de la Recherche Scientifique · FRUniversity of Luxembourg · LU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to evaluate the immunological effects on human macrophages of four endocrine disruptor compounds (EDCs) using the differentiated human THP-1 cell line as a model. We studied first the effects of these EDCs, including Bisphenol A (BPA), di-ethylhexyl-phthalate (DEHP), dibutyl phthalate (DBP) and 4-tert-octylphenol (4-OP), either alone or in combination, on cytokine secretion, and phagocytosis. We then determined whether or not these effects were mediated by estrogen receptors via MAPK pathways. It was found that all four EDCs studied reduced strongly the phagocytosis of the differentiated THP-1 cells and that several of these EDCs disturbed also TNF-α, IL-1 β and IL-8 cytokine secretions. Furthermore, relative to control treatment, decreased ERK 1/2 phosphorylation was always associated with EDCs treatments-either alone or in certain combinations (at 0.1 μM for each condition). Lastly, as treatments by an estrogen receptor antagonist suppressed the negative effects on ERK 1/2 phosphorylation observed in cells treated either alone with BPA, DEHP, 4-OP or with the combined treatment of BPA and DEHP, we suggested that estrogen receptor-dependent pathway is involved in mediating the effects of EDCs on human immune system. Altogether, these results advocate that EDCs can disturb human immune response at very low concentrations.

Indexed as

Benzhydryl CompoundsBisphenol A CompoundsCell LineDibutyl PhthalateDiethylhexyl PhthalateDose-Response Relationship, DrugEndocrine DisruptorsGene Expression RegulationHumansInterleukin-1betaInterleukin-8MacrophagesMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3PhagocytosisPhenols4-tert-octylphenolBenzhydryl Compoundsbisphenol ABisphenol A CompoundsDibutyl PhthalateDiethylhexyl PhthalateEndocrine DisruptorsInterleukin-1betaInterleukin-8MAPK1 protein, humanMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3PhenolsReceptors, EstrogenTumor Necrosis Factor-alpha

Identifiers

PMID26133781
PMCPMC4489735
OpenAlexW782651221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.